13D Filing: JFL Capital Management and Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Joseph F. Lawler's JFL Capital disclosed a 7.1% activist stake in Merrimack Pharmaceuticals.

Keep Reading →